These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29671896)

  • 1. Subgroups from regression trees with adjustment for prognostic effects and postselection inference.
    Loh WY; Man M; Wang S
    Stat Med; 2019 Feb; 38(4):545-557. PubMed ID: 29671896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of subgroups with differential treatment effects for longitudinal and multiresponse variables.
    Loh WY; Fu H; Man M; Champion V; Yu M
    Stat Med; 2016 Nov; 35(26):4837-4855. PubMed ID: 27346729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regression tree approach to identifying subgroups with differential treatment effects.
    Loh WY; He X; Man M
    Stat Med; 2015 May; 34(11):1818-33. PubMed ID: 25656439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.
    Altstein LL; Li G; Elashoff RM
    Stat Med; 2011 Mar; 30(7):709-17. PubMed ID: 21394747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction trees with censored survival data.
    Su X; Zhou T; Yan X; Fan J; Yang S
    Int J Biostat; 2008 Jan; 4(1):Article 2. PubMed ID: 20231911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials.
    Zhang Z; Chen R; Soon G; Zhang H
    Stat Med; 2018 Jan; 37(1):1-11. PubMed ID: 28948633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroup identification using covariate-adjusted interaction trees.
    Steingrimsson JA; Yang J
    Stat Med; 2019 Sep; 38(21):3974-3984. PubMed ID: 31162690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confidence interval estimation for the changepoint of treatment stratification in the presence of a qualitative covariate-treatment interaction.
    Haller B; Mansmann U; Dobler D; Ulm K; Hapfelmeier A
    Stat Med; 2020 Jan; 39(1):70-96. PubMed ID: 31701549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inference on covariate effect types for treatment effectiveness in a randomized trial with a binary outcome.
    Chiba Y
    Clin Trials; 2019 Jun; 16(3):237-245. PubMed ID: 30760066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stochastic multiple imputation algorithm for missing covariate data in tree-structured survival analysis.
    Wallace ML; Anderson SJ; Mazumdar S
    Stat Med; 2010 Dec; 29(29):3004-16. PubMed ID: 20963751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Cox regression models for composite time-to-event endpoints with component-wise censoring in randomized trials.
    Speiser JL; Ambrosius WT; Pajewski NM
    Clin Trials; 2023 Oct; 20(5):507-516. PubMed ID: 37243355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian additive decision trees of biomarker by treatment interactions for predictive biomarker detection and subgroup identification.
    Zhao Y; Zheng W; Zhuo DY; Lu Y; Ma X; Liu H; Zeng Z; Laird G
    J Biopharm Stat; 2018; 28(3):534-549. PubMed ID: 29020511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recursive partitioning approach for subgroup identification in individual patient data meta-analysis.
    Mistry D; Stallard N; Underwood M
    Stat Med; 2018 Apr; 37(9):1550-1561. PubMed ID: 29383818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of subgroups via partial linear regression modeling approach.
    Zhou Y; Yuan A; Tan MT
    Biom J; 2022 Mar; 64(3):506-522. PubMed ID: 34897799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some issues in estimating the effect of prognostic factors from incomplete covariate data.
    Vach W
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):57-72. PubMed ID: 9004383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.